ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Bliss GVS Pharma Ltd announced the resignation of Mr. Sachin Saboo, General Manager – Regulatory & Clinical, effective from the close of business hours on July 24, 2026.
Bliss GVS Pharma appointed Rahul Adakmol as CEO, effective July 15, 2026. Narsimha Shibroor Kamath stepped down as CEO but remains Managing Director.
Mr. Santosh Parab completed his final term as Independent Director on May 25, 2026. This planned leadership change follows statutory term limits for independent directors.
Bliss GVS Pharma Limited has appointed Mr. Vijayanarayanan Mahadevan and Mr. Deepak Rameshchandra Shah as Additional Independent Directors for five-year terms effective April 03, 2026. Both appointees are seasoned finance professionals and Chartered Accountants. The appointments are subject to shareholder approval via postal ballot.